Latest Financial Performance News

Helloworld Travel Limited reported a 4.1% increase in net profit after tax for FY25 despite revenue and transactional value declines amid economic headwinds. The company completed full acquisition of Mobile Travel Agents and provided confident FY26 EBITDA guidance of $64-$72 million.

ASX Limited reaffirms its FY26 expense growth guidance while detailing progress on its five-year transformation and addressing regulatory challenges. Strong FY25 financial results and a robust market pipeline underpin the company’s outlook.

Insurance Australia Group (IAG) reported strong FY25 results and upgraded its FY26 guidance, reflecting the completed RACQ acquisition and ongoing strategic growth initiatives.

Cochlear Limited reports steady FY25 financials alongside the launch of its innovative Nucleus Nexa cochlear implant system, setting the stage for projected double-digit profit growth in FY26.

Vault Minerals delivered a strong September quarter with record gold production and advancing key infrastructure upgrades, setting the stage for significant free cash flow growth in FY27.

Northern Star Resources reported steady gold production and disciplined costs in Q1 FY26, with the KCGM Mill Expansion project progressing on schedule for early FY27 commissioning. Despite minor operational disruptions, the company maintains its full-year guidance and a robust financial position.

Bellevue Gold Limited reported robust cash flow for the September quarter, enabling a substantial early repayment on its project loan and maintaining a strong cash position.

Acumentis Group Limited reported a robust FY25 with a 35% jump in operating profit, driven by strategic diversification and operational efficiency. The company is optimistic about FY26, anticipating economic improvements and new growth avenues.

Acumentis delivered a 3.4% revenue increase to $58.1 million at its 2025 AGM, highlighting diversification and a positive outlook for FY26 amid easing inflation and expected rate cuts.

GR Engineering Services Limited reported a robust FY25 with revenue climbing to $479 million and EBITDA surging to $57.2 million, supported by successful project completions and an expanded contract pipeline. The company declared a higher fully franked dividend and maintains a strong cash position as it looks ahead to FY26.

Sigma Healthcare’s 2025 AGM reveals a robust year of transformation post-merger with Chemist Warehouse, highlighted by upgraded synergy targets and impressive financial gains.

Sigma Healthcare’s transformative merger with Chemist Warehouse has propelled the company into Australia’s top 20 ASX firms, with FY25 results exceeding expectations and synergy targets nearly doubling.